Skip to content
StockMarketAgent
Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

SNSE/ABTCL stock hub

SNSE/ABTCL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SNSE/ABTCLis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
130.9T
Santiago Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SNSE/ABTCL
In the news

Latest news · SNSE/ABTCL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15
P25 n/aP50 n/aP75 n/a
Trailing P/E22.5
P25 n/aP50 n/aP75 n/a
ROE12.3
P25 n/aP50 n/aP75 n/a
ROIC9.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SNSE/ABTCL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
203
Groups with data
11
Currency
USD
Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
CL
Employees
115,000
Employees Change
7,000%
Employees Change Percent
6.09
Enterprise value
CLP 155.4T
Exchange
Santiago Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Electromedical and Electrotherapeutic Apparatus
Last refreshed
2026-05-10
Market cap
CLP 130.9T
Price
CLP 108,200
Price currency
CLP
Rev Per Employee
364,914,277.04x
Sic
3845
Symbol
snse/ABTCL
Website
https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.44%
EV Earnings
26.74x
EV/EBIT
20.32x
EV/EBITDA
14.37x
EV/FCF
22.66x
EV/Sales
3.86x
FCF yield
5.24%
Forward P/E
14.97x
P/B ratio
2.67x
P/E ratio
22.52x
P/S ratio
3.12x
PE Ratio10 Y
50.34x
PE Ratio3 Y
27.72x
PE Ratio5 Y
27.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
19.01%
EBITDA Margin
26.02%
FCF margin
16.35%
Gross margin
56.5%
Gross Profit
CLP 23.7T
Gross Profit Growth
7.63%
Gross Profit Growth Q
6.52%
Gross Profit Growth3 Y
3.39%
Gross Profit Growth5 Y
3.61%
Net Income
CLP 5.8T
Net Income Growth
-53.52%
Net Income Growth Q
-18.72%
Net Income Growth3 Y
2.62%
Net Income Growth5 Y
1.88%
Pretax Margin
18.03%
Profit Margin
13.91%
Profit Per Employee
CLP 50.5M
ROA
5.59
Roa5y
6.84
ROCE
9.32
ROE
12.33
Roe5y
19.7
ROIC
9.63
Roic5y
14.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr1y
2.11%
Cagr3y
7.34%
Div CAGR3
9.04%
Div CAGR5
325.33%
EPS Growth
-53.65
EPS Growth Q
-19.74
EPS Growth3 Y
2.78
EPS Growth5 Y
2.27
FCF Growth
10.83%
FCF Growth Q
-1.82%
FCF Growth3 Y
2.64%
FCF Growth5 Y
-0.61%
OCF Growth
5.74%
OCF Growth Q
-7.2%
OCF Growth10 Y
12.67%
OCF Growth3 Y
3.01%
OCF Growth5 Y
-0.74%
Revenue Growth
6.59x
Revenue Growth Q
7.78x
Revenue Growth3 Y
2.83x
Revenue Growth5 Y
3.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
CLP 0.47
Assets
CLP 102.7T
Cash
CLP 6.8T
Current Assets
CLP 22.7T
Current Liabilities
CLP 16.4T
Debt
CLP 31.7T
Debt EBITDA
CLP 2.81
Debt Equity
CLP 0.65
Debt FCF
CLP 4.63
Equity
CLP 49T
Interest Coverage
16.01
Liabilities
CLP 53.7T
Long Term Assets
CLP 79.9T
Long Term Liabilities
CLP 37.3T
Net Cash
CLP -25T
Net Cash By Market Cap
CLP -19.06
Net Debt EBITDA
CLP 2.29
Net Debt Equity
CLP 0.51
Net Debt FCF
CLP 3.64
Tangible Book Value
CLP -962.3B
Tangible Book Value Per Share
CLP -552

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.39
Inventory Turnover
2.88
Net Working Capital
CLP 4T
Quick ratio
0.84
Working Capital
CLP 6.6T
Working Capital Turnover
CLP 4,857

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.03%
Dividend Growth
3.82%
Dividend Growth Years
6%
Dividend per share
CLP 2,255
Dividend Years
7
Dividend Yield
2.08%
Ex Div Date
2026-04-15
Last Dividend
CLP 558
Payout Frequency
Quarterly
Payout Ratio
66.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

28
MetricValue
1Y total return
2.11%
200-day SMA
108,200
3Y total return
23.68%
50-day SMA
108,200
50-day SMA vs 200-day SMA
50under200
All Time High
126,000
All Time High Change
-14.13%
All Time High Date
2025-03-12
All Time Low
77,790
All Time Low Change
39.09%
All Time Low Date
2021-06-02
ATR
357.4
High52
119,500
High52 Date
2025-10-29
High52ch
-9.46%
Low52
88,956
Low52 Date
2026-04-10
Low52ch
21.63%
Ma50ch
0%
Price vs 200-day SMA
0%
RSI
89.81
RSI Monthly
88.9
RSI Weekly
97.75
Sharpe ratio
-1.83x
Total Return
2.05%
Tr YTD
1.04
Tr1m
0.52%
Tr3m
0.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CLP 8T
Operating Income Growth
9.76
Operating Income Growth Q
-18.26
Operating Income Growth3 Y
3.54
Operating Income Growth5 Y
4.05
Operating margin
19.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
1,731,228,666%
Net Borrowing
15,951,417,130,000
Shares Insiders
0.49%
Shares Institutions
80.5%
Shares Qo Q
0%
Shares Yo Y
0.03%
Short Ratio
1.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Adjusted FCF
CLP 6.2T
Average Volume
0.1x
Bv Per Share
27,790.5
CAPEX
CLP -1.9T
Ch3y
16.37
Change
0%
Close
108,200
Depreciation Amortization
2,819,150,270,000
Earnings Date
2026-04-16
EBIT
CLP 8T
EBITDA
CLP 10.9T
EPS
CLP 3,319
F Score
5
FCF
CLP 6.9T
FCF EV Yield
4.41x
Financing CF
12,142,127,610,000
Fiscal Year End
December
Founded
1,888
Goodwill
31,392,125,090,000
Graham Number
66156.70162
Graham Upside
-38.86
Income Tax
CLP 1.7T
Investing CF
-20,712,002,040,000
Is Primary Listing
0
Last Earnings Date
2026-04-16
Last Report Date
2026-03-31
Lynch Fair Value
CLP 24,019
Lynch Upside
-77.8
Ma150
108,200
Ma150ch
0%
Ma20
108,200
Ma20ch
0%
Net CF
251,973,090,000
Next Earnings Date
2026-07-15
P FCF Ratio
19.09
P OCF Ratio
14.88
Payment Date
2026-05-15
Ppne
11,031,496,330,000
Price Date
2026-05-08
Price EBITDA
CLP 11.99
Relative Volume
2,000x
Revenue
41,965,141,860,000x
SBC By Revenue
1.53x
Share Based Comp
643,414,680,000
Tax By Revenue
4.12x
Tax Rate
22.87%
Tr6m
1.04%
Z Score
3.65
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SNSE/ABTCL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.1%
$2255 annual per share
Payout ratio
+66.7%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+325.3%
6 consecutive years of growth
Total shareholder yield
+2.1%
Next ex-dividend date: 2026-04-15
Performance

SNSE/ABTCL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+2.1%
S&P 500 1Y: n/a
3Y total return
+23.7%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SNSE/ABTCL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+80.5%
Share of float held by funds and institutions
Insider ownership
+0.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
1.9 days to cover
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

SNSE/ABTCL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
89.8
Above 70: short-term overbought
Price vs 200-day MA
0.0%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-1.83
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SNSE/ABTCL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current snse/ABTCL stock rating?

snse/ABTCL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full snse/ABTCL analysis?

The full report lives at /stocks/snse/ABTCL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for snse/ABTCL?

The latest report frames snse/ABTCL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the snse/ABTCL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

snse/ABTCL stock profile: metrics, valuation and analysis | AI-Agent voor de Aandelenmarkt